Rachel King

Co-Founder at GlycoMimetics, Inc.

Rachel King

Rachel King

Co-Founder at GlycoMimetics, Inc.

Overview
Career Highlights

Genetic Therapy, Inc.
GlycoMimetics, Inc.

RelSci Relationships

1531

Number of Boards

9

Birthday

1960

Age

61

Relationships
RelSci Relationships are individuals Rachel King likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Director, President & Chief Executive Officer at MaxCyte, Inc.

Relationship likelihood: Strong

Director at GlycoMimetics, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Vice President at Nashua Corp.

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

Senior Vice President, Research & Chief Scientific Officer at GlycoMimetics, Inc.

Relationship likelihood: Strong

Partner Emeritus at New Enterprise Associates, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Carrick Therapeutics Ltd.

Relationship likelihood: Strong

Physician at The Brigham & Women's Hospital, Inc.

Relationship likelihood: Strong

Co-Founder at MacroGenics, Inc.

Relationship likelihood: Strong

Chairman & President at Maryland Health Care Product Development Corp.

Relationship likelihood: Strong

Paths to Rachel King
Potential Connections via
Relationship Science
You
Rachel King
Co-Founder at GlycoMimetics, Inc.
Education
MBA

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

BA

Founded in 1769, Dartmouth is a member of the Ivy League and consistently ranks among the world's greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts & Sciences and its three leading professional schools—the Geisel School of Medicine, Thayer School of Engineering, and the Tuck School of Business.

Career History
Co-Founder
2003 - Current

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

Senior Vice President
1999 - 2001

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Vice President, Planning
1996 - 1998

Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.

Boards & Committees
Member, Advisory Board
Tenure Unconfirmed
Director
Tenure Unconfirmed

PROVIDE AND SUPPORT STEM SKILLS AND CAREER AWARENESS AMONG UNDERSERVED COMMUNITIES.

Director
Tenure Unconfirmed
Political Donations
$500
2020

Vice President, General Counsel at WasteZero

$500
2019

Senator from Minnesota

$500
2019

President at Executive Office of the President Under Joseph R. Biden

Transactions
Details Hidden

GlycoMimetics, Inc. raised money in a private placement transaction

Investments
Details Hidden

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Rachel King. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Rachel King's profile does not indicate a business or promotional relationship of any kind between RelSci and Rachel King.